Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation

Mise à jour : Il y a 4 ans
Référence : NCT00080236

Femme et Homme

Extrait

The purpose of the study is to test the safety and effectiveness of IDN-6556 in preventing liver damage that normally occurs when livers are transported before being transplanted and in the immediate post-transplant period.


Critère d'inclusion

  • Liver Transplantation ,Hepatitis ,Cholestasis ,Carcinoma, hepatocellular

Liens